[1]迟雁青,张涛,康英丽,等.氨基甲酰促红素对大鼠肾脏缺血再灌注损伤的保护作用[J].第三军医大学学报,2019,41(16):1545-1551.
 CHI Yanqing,ZHANG Tao,KANG Yingli,et al.Protective effect of carbamoylated erythropoietin against renal ischemia-reperfusion injury in rats[J].J Third Mil Med Univ,2019,41(16):1545-1551.
点击复制

氨基甲酰促红素对大鼠肾脏缺血再灌注损伤的保护作用(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第16期
页码:
1545-1551
栏目:
基础医学
出版日期:
2019-08-30

文章信息/Info

Title:
Protective effect of carbamoylated erythropoietin against renal ischemia-reperfusion injury in rats
作者:
迟雁青张涛康英丽余柯刘茂东李英
河北医科大学第三医院肾内科,河北省肾脏病研究中心
Author(s):
CHI Yanqing ZHANG Tao KANG Yingli YU Ke LIU Maodong LI Ying
Department of Nephrology, Hebei Provincial Research Center for Kidney Diseases, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, 050051, China
 
关键词:
氨基甲酰促红素缺血再灌注损伤急性肾损伤
Keywords:
carbamoylated erythropoietin renal ischemia-reperfusion injury acute kidney injury
分类号:
R364.12;R699.2;R977.9
文献标志码:
A
摘要:

目的 探讨氨基甲酰促红细胞生成素(carbamoyl-erythropoietin,CEPO)对大鼠肾脏及人肾小管上皮细胞(HK-2)缺血再灌注损伤的保护作用。方法 构建SD大鼠肾脏缺血再灌注肾损伤模型,造模后0、24、48 h按照5 000 U/kg的剂量向腹腔内注射促红细胞生成素(EPO)或者CEPO,与肾脏缺血再灌注肾损伤模型组和假手术组进行对比分析,观察各组大鼠血清尿素氮(BUN)、血肌酐(Scr)、红细胞比容(Hct),肾组织匀浆超氧化物歧化酶(SOD)、丙二醛(MDA)、肿瘤坏死因子-α(TNF-α),血清中IL-6、IL-10变化,肾组织PAS染色观察肾脏病理改变。对HK-2细胞进行缺血再灌注损伤处理,同时给予EPO和CEPO干预处理,实时定量RT-PCR检测IL-6、IL-10、TNF-α mRNA表达,Western blot检测IL-6、IL-10和凋亡相关蛋白cleaved-Caspase 3的蛋白表达。结果在大鼠肾脏缺血再灌注模型中,EPO或者CEPO干预治疗后,大鼠Scr、BUN水平明显降低;血清中促炎因子IL-6水平明显降低,抗炎因子IL-10水平明显提升;肾组织匀浆中MDA、TNF-α水平明显降低,SOD水平明显升高(P<0.05);PAS染色显示肾损伤明显减轻,且CEPO较EPO能起到更好的效果,CEPO治疗组Hct升高较EPO治疗组更加缓和(P<0.05)。HK-2细胞缺血再灌注模型中,EPO和CEPO能降低缺血再灌注HK-2细胞内TNF-α和IL-6 mRNA的表达,增加IL-10 mRNA和蛋白的表达,降低IL-6和cleaved-Caspase 3蛋白的表达,且CEPO能显示出更好的效果(P<0.05)。结论 CEPO可能通过减轻炎症和减少凋亡发挥缓解缺血再灌注对肾脏的损伤作用,并且相对EPO能减轻Hct升高的副作用。

Abstract:

Objective To investigate the protective effect of carbamoyl-erythropoietin (CEPO) against ischemia-reperfusion (IR) injury in rat kidneys and in human renal tubular epithelial cells (HK-2). MethodsIn a SD rat model of renal IR injury, EPO or CEPO was intraperitoneally injected at the dose of 5 000 U/kg at 0, 24, and 48 h after renal IR. Serum levels of urea nitrogen (BUN) and creatinine (Scr), hematocrit (Hct), and the levels of superoxide dismutase (SOD), malondialdehyde (MDA), and tumor necrosis factor-α (TNF-α) in the kidney homogenate were detected; serum levels of interleukin-6 (IL-6) and IL-10 were detected and PAS staining was used for assessment of the renal pathologies. HK-2 cells were exposed to IR injury and treated with EPO or CEPO, and the mRNA expressions of IL-6, IL-10, and TNF-α were detected using Real-time PCR; the protein expressions of IL-6, IL-10, and cleaved Caspase-3 were analyzed with Western blotting. ResultsIn the rat model of renal IR injury, Scr, BUN and IL-6 levels were reduced and serum IL-10 level was increased significantly after treatment with EPO or CEPO, which also significantly lowered the levels of MDA and TNF-α and increased SOD levels in the kidney homogenate (P<0.05). PAS staining showed a significant improvement of renal pathological damages after the treatments, and the effect was more obvious with CEPO. CEPO treatment resulted in a milder increase in Hct as compared with EPO (P<0.05). In HK-2 cells with IR injury, both EPO and CEPO treatment reduced the mRNA expressions of TNF-α and IL-6, increased the mRNA and protein expressions of IL-10, and reduced the protein expressions of IL-10 and cleaved Caspase-3, and these effects were significantly more obvious with CEPO than with EPO treatment (P<0.05). ConclusionCEPO can alleviate renal IR injury in rats by reducing inflammation and apoptosis, and can more effectively suppress the elevation of Hct than EPO in the rat models.

参考文献/References:

[1]KEZIC' A, STAJIC N, THAISS F. Innate immune response in kidney Ischemia/Reperfusion injury: potential target for therapy[J]. J Immunol Res, 2017, 2017: 6305439. DOI: 10.1155/2017/6305439. 
[2]YASSIN M M, HARKIN D W, BARROS D’SA A A, et al. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction[J]. World J Surg, 2002, 26(1): 115-121. DOI: 10.1007/s00268-001-0169-2.
[3]BRINES M, GRASSO G, FIORDALISO F, et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunitheteroreceptor[J]. Proc Natl Acad Sci U S A, 2004, 101(41): 14907-14912. DOI: 10.1073/pnas.0406491101.
[4]FRANCIS A, BAYNOSA R.Ischaemia-reperfusion injury and hyperbaric oxygen pathways: A review of cellular mechanisms[J]. Diving Hyperb Med, 2017, 47(2): 110-117.
[5]XU Z, ZHAO K, HAN P, et al.Octreotide ameliorates renal Ischemia/Reperfusion injury via antioxidation and anti-inflammation[J]. Transplant Proc, 2017, 49(8): 1916-1922. DOI: 10.1016/j.transproceed.2017.05.008.
[6]REN C C, ZHU W, WANG Q W, et al. The renal protect function of erythropoietin after release of bilateral ureteral obstruction in a rat model[J]. Clin Sci, 2018, 132(18): 2071-2085. DOI: 10.1042/CS20180178.
[7]SHARPLES E J, YAQOOB M M. Erythropoietin and acute renal failure[J]. Semin Nephrol, 2006, 26(4): 325-331. DOI: 10.1016/j.semnephrol.2006.05.010.
[8]ABE T, ISAKA Y, IMAMURA R, et al.Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis[J]. Cell Transplant, 2012, 21(2/3): 571-580. DOI: 10.3727/096368911X605501.
[9]TGEL F E, AHLSTROM J D, YANG Y, et al. Carbamylated erythropoietin outperforms erythropoietin in the treatment of AKI-on-CKD and other AKI models[J]. J Am Soc Nephrol, 2016, 27(11): 3394-3404. DOI: 10.1681/ASN.2015091059.
[10]CASSIS P, AZZOLLINI N, SOLINI S, et al. Bothdarbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats[J]. Transplantation, 2011, 92(3): 271-279. DOI: 10.1097/TP.0b013e3182241106.
[11]CERNARO V, SFACTERIA A, RIFICI C, et al.Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: An immunohistochemical study for β-catenin and c-kit expression[J]. J Nephrol, 2017, 30(3): 385-391. DOI: 10.1007/s40620-016-0353-y.
[12]MALEK M, NEMATBAKHSH M. Renal ischemia/reperfusion injury; from pathophysiology totreatment[J]. J Renal Inj Prev, 2015, 4(2): 20-27. DOI: 10.12861/jrip.2015.06.
[13]ZHAO L S, XU L N, TAO X F, et al. Protective effect of the total flavonoids fromrosa laevigata michx fruit on renal ischemia-reperfusion injury through suppression of oxidative stress and inflammation[J]. Molecules, 2016, 21(7): E952. DOI: 10.3390/molecules21070952.
[14]OLIVEIRA R C, BRITO M V, RIBEIRO R F Júnior, et al. Influence of remote ischemic conditioning and tramadol hydrochloride on oxidative stress in kidney ischemia/reperfusion injury in rats[J]. Acta Cir Bras, 2017, 32(3): 229-235.DOI: 10.1590/S0102-865020170030000007.
[15]GODET C, GOUJON J M, PETIT I, et al. Endotoxin tolerance enhances interleukin-10 renal expression and decreases ischemia-reperfusionrenal injury in rats[J]. Shock, 2006, 25(4): 384-388.DOI: 10.1097/01.shk.0000209528.35743.54.
[16]BANAEI S, AHMADIASL N, ALIHEMMATI A. Combination anti-apoptotic effect of erythropoietin and melatonin on ischemia reperfusion-induced renal injury in rats[J]. Acta Med Iran, 2016, 54(10): 624-630.
[17]WICHAPOON B, PUNSAWAD C, VIRIYAVEJAKUL P. Expression of cleaved caspase-3 in renal tubular cells in plasmodium falciparum malaria patients[J]. Nephrology (Carlton), 2017, 22(1): 79-84. DOI: 10.1111/nep.12715.
[18]TANG Z H, SUN X C, SHI Q H, et al. Beneficial effects of carbamylated erythropoietin against oxygen-glucose deprivation/reperfusion-induced astrocyte swelling: proposed molecular mechanisms of action[J]. Neurosci Lett, 2012, 530(1): 23-28. DOI: 10.1016/j.neulet.2012.09.029. 
[19]LI R, ZHANG L M, SUN W B. Erythropoietin rescues primary rat cortical neurons frompyroptosis and apoptosis via Erk1/2-Nrf2/Bach1 signal pathway[J]. Brain Res Bull, 2017, 130: 236-244. DOI: 10.1016/j.brainresbull.2017.01.016.
[20]ZOU Y R, ZHANG J, WANG J, et al. Erythropoietin receptor activation protects the kidney from Ischemia/Reperfusion-induced apoptosis by activating ERK/p53 signalpathway[J]. Transplant Proc, 2016, 48(1): 217-221. DOI: 10.1016/j.transproceed.2016.01.009.
 

相似文献/References:

[1]陈新,成名翔,龚建平,等.沉默供体肝脏内核糖体蛋白S3基因减轻大鼠移植肝脏缺血再灌注损伤[J].第三军医大学学报,2011,33(14):1441.
 Chen Xin,Cheng Mingxiang,Gong Jianping,et al.Silencing ribosome protein S3 gene in donor livers reduces ischemia/reperfusion injury following orthotopic liver transplantation in rats[J].J Third Mil Med Univ,2011,33(16):1441.
[2]徐广民,陶国才,易斌.异氟烷对大鼠肝脏缺血再灌注损伤时细胞间黏附分子-1表达的影响[J].第三军医大学学报,2008,30(03):241.
 XU Guang-min,TAO Guo-cai,YI Bin.Effect of Isoflurane on ICAM-1 expression in rats during liver ischemiareperfusion injury[J].J Third Mil Med Univ,2008,30(16):241.
[3]许永庆,戴朝六,崔凯,等.谷氨酰胺在肝脏缺血再灌注损伤中对肠道黏膜保护作用[J].第三军医大学学报,2007,29(11):1050.
 XU Yong-qing,DAI Chao-liu,CUI Kai,et al.Protective effect of glutamine on intestinal mucosa during hepatic ischemia/reperfusion injury in rats[J].J Third Mil Med Univ,2007,29(16):1050.
[4]方针强,刘永亮,王祥卫,等.hBMP-7修饰的骨髓间充质干细胞对肾脏BMP-7的影响[J].第三军医大学学报,2011,33(15):1590.
 Fang Zhenqiang,Liu Yongliang,Wang Xiangwei,et al.hBMP-7-modified bone marrow mesenchymal stem cells attenuate kidney ischemia-reperfusion injury in rabbits[J].J Third Mil Med Univ,2011,33(16):1590.
[5]刘志恒,禹晓东,王海强,等.维生素C与小剂量激素联用对急性脊髓缺血再灌注损伤的保护作用[J].第三军医大学学报,2010,32(08):814.
 Liu Zhiheng,Yu Xiaodong,Wang Haiqiang,et al.Protective effect of methylprednisolone combined with ascorbic acid on acute spinal cord I/R injury in rabbits[J].J Third Mil Med Univ,2010,32(16):814.
[6]伊远学,刘晓平,李宝金,等.微囊化腺病毒介导的Bcl-2基因转染对缺血再灌注损伤肠黏膜的保护作用[J].第三军医大学学报,2010,32(14):1516.
 Yi Yuanxue,Liu Xiaoping,Li Baojin,et al.Microencapsulated adenovirus-mediated gene transfer of Bcl-2 protects rat intestinal mucosa after ischemia-reperfusion injury[J].J Third Mil Med Univ,2010,32(16):1516.
[7]王群英,刘新伟,杨海燕,等.硝酸甘油预处理的心肌保护作用及对Caveolin-3表达的影响[J].第三军医大学学报,2010,32(24):2627.
 Wang Qunying,Liu Xinwei,Yang Haiyan,et al.Nitroglycerin preconditioning protects heart ischemia-reperfusion injury in rats by improving Caveolin-3 expression[J].J Third Mil Med Univ,2010,32(16):2627.
[8]孙科,陈勇,刘作金,等.牛磺酸预处理抑制IRAK-4信号通路对大鼠移植肝脏再灌注损伤的保护机制[J].第三军医大学学报,2009,31(11):1017.
 SUN Ke,CHEN Yong,LIU Zuo-jin,et al.Protective mechanisms of IRAK-4 inhibited by taurine preconditioning in liver graft ischemia/reperfusion injury in rats[J].J Third Mil Med Univ,2009,31(16):1017.
[9]于月新,李巨,陈佳,等.兔附件扭转复位后对卵巢缺血再灌注损伤的影响[J].第三军医大学学报,2011,33(21):2302.
[10]税春玲,杨建平,唐佩灵,等.丙泊酚后处理对肾性高血压大鼠心肌的保护作用[J].第三军医大学学报,2016,38(06):609.
 Shui Chunling,Yang Jianping,Tang Peiling,et al.Myocardial protective effect of propofol postconditioning in renal hypertensive rats[J].J Third Mil Med Univ,2016,38(16):609.

更新日期/Last Update: 2019-08-22